0.30 | 2.78%
| Price and Volume | |
|---|---|
| Recent Price | 10.79 |
| 52 Week High | 15.79 |
| 52 Week Low | 6.75 |
| Avg. Daily Vol. (Mil) | 0.42 |
| Beta (3 year) | 0.52 |
| Share Related Items | |
| Mkt Cap (Mil) | 739.65 |
| Shares Out (Mil) | 68.55 |
| Float (Mil) | 67.24 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.10 |
| Current Ratio | 5.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 9.00 |
| Price/Book | 7.43 |
| Price/Cash Flow | -17.70 |
| Per Share Data | |
| Earnings | -0.70 |
| Sales | 1.20 |
| Book Value | 1.45 |
| Cash Flow | -0.61 |
| Business Summary | |
|---|---|
| Dexcom, Inc. is designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. | |
| General Information | |
| 6340 Sequence Drive
San Diego, CA 92121 |
|
| www.dexcom.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 502 | |
| CEO: Terrance H. Gregg | |
| Short Interest | |
| Current Month (Mil) | 6.40 |
| Previous Month (Mil) | 6.16 |
| Short Interest Ratio (Days) | 14.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -39.80 |
| Return on Investments | -47.00 |
| Profitability | |
| Gross Margin | 55.10 |
| EBIT Margin | -58.70 |
| Profit Margin | -57.10 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,580.69 | 1,332.42 | 2,870.99 | 17.31 |
Oil *
106.75
|
|
UP
125.86 |
UP
14.60 |
UP
33.46 |
DOWN
0.14 |
10 Yr
1.73%
SPDR Gold
151.02
|
|
+1.01%
|
+1.11%
|
+1.18%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet